目的:探索四象体质类型与血脂异常的关系.方法:对790例体检人群进行生活方式调查、四象体质类型调查和血脂等生化指标测定,采用SPSS 18.0软件进行x2检验和logistic回归分析.结果:①太阴体质是血脂异常的危险因素(OR=2.695,95％CI:[1.777,4.088]);②无论哪种体质,年龄、肥胖均与血脂异常相关,其肥胖类型对不同体质血脂异常人群的影响程度不尽相同.结论:四象体质类型可能是血脂异常的危险因素.

目的 比较分析中医与西医治疗抑郁症随机对照试验(Randomized Controlled Trial,RCT)的结局指标及测量工具使用现状,为今后研究开展提供参考.方法 检索6个临床研究注册平台,获取中医和西医治疗成人抑郁症RCT的注册信息;检索9个中英文数据库,补充中医治疗抑郁症的RCT文献;提取并分析其报告的结局指标及测量工具.结果 共获注册的西医RCT 1033项,中医RCT 195项(注册29项、发表166项).西医RCT使用的结局指标共581个,评价内容全面涵盖心理功能和躯体功能、日常活动能力、环境反应以及生存质量等结局指标域,涉及406个量表.11％研究关注了安全性结局.中医RCT使用的结局指标共118个,评价内容仅涵盖心理功能和躯体功能、药物不良反应和中医证候等结局指标域,涉及14个量表;极少文献使用了中医疗效评价指标;安全性结局报告率为47％;86.7％研究使用汉密尔顿抑郁量表作为测量工具.结论 西医研究使用的结局指标及测量工具涵盖范围广且研究间差异较大,而中医研究使用的结局指标及测量工具范围小且集中.今后开展的抑郁症临床研究在结合研究目的的基础上,可参考国际抑郁症核心指标集,结合中医药潜在作用点来选择结局指标及适合的测量工具以评价中医药疗效和安全性.

Gegen (Radix Puerariae Lobatae), the root of Pueraria lobata, is an edible and medicinal herb which has been used in treating diabetic symptoms in the orient for thousands of years. We present an evidence map of the efficacy and safety of Gegen and Gegen formulas (GGFs) that use Gegen as an essential herb for diabetes, and also its mechanism of actions. We comprehensively searched the ancient medical records to identify empirical evidence; conducted a systematic review (SR) based on moderate- to high-quality randomized controlled trials (RCTs) to synthesize the clinical evidence; and reviewed the possible mechanisms of its antidiabetic effects. Empirical application of Gegen in treating diabetic symptoms dated back to more than 2000 years ago. Common herbs used in RCTs that accompany with Gegen included Radix et Rhizoma Glycyrrhizae, Radix et Rhizoma Ginseng, Rhizoma Dioscoreae, Poria, and Radix Ophiopogonis. The combinations used today are consistent with their usage in ancient times. Results of the SR showed that GGFs could benefit patients with type 2 diabetes for blood glucose control. When in combination with hypoglycemic agents or insulin, GGFs enhanced the glucose-lowering effect as well as the lipid-lowering effects. Also, the incidence and the risk of adverse events (AE), especially the hypoglycemic episodes, were lower in the combination group. No serious or life-threatening AE was reported. The experimental evidence presented that Gegen and GGFs might exert and enhance the anti-diabetic effects through activation of multiple mechanisms, such as reducing insulin resistance, increasing insulin release, inhibiting glucose absorption and reabsorption, and improving insulin sensitivity, glucose uptake, and metabolism.